Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.41 |
| ▸ | LMNA | P02545 | 1/20 | 0.41 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.41 |
| ▸ | HTT | P42858 | 1/20 | 0.41 |
| ▸ | NPC1 | O15118 | 1/20 | 0.32 |
| ▸ | RAB9A | P51151 | 1/20 | 0.32 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.31 |
| ▸ | MAPT | P10636 | 1/20 | 0.31 |
| ▸ | PKM | P14618 | 1/20 | 0.31 |
| ▸ | CDK5 | Q00535 | 1/20 | 0.31 |
| ▸ | CDK5R1 | Q15078 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL695780 | 0.79 | L3MBTL1 (0.36) | L3MBTL1LMNAMAPK1HTTNPC1 | |
| SCHEMBL6345644 | 0.79 | L3MBTL1 (0.36) | L3MBTL1LMNAMAPK1HTTNPC1 | |
| SCHEMBL695779 | 0.79 | L3MBTL1 (0.36) | L3MBTL1LMNAMAPK1HTTNPC1 | |
| SCHEMBL696078 | 0.74 | L3MBTL1 (0.39) | L3MBTL1LMNAMAPK1HTTNPC1 | |
| SCHEMBL6970352 | 0.74 | L3MBTL1 (0.39) | L3MBTL1LMNAMAPK1HTTNPC1 | |
| SCHEMBL696077 | 0.74 | L3MBTL1 (0.39) | L3MBTL1LMNAMAPK1HTTNPC1 | |
| SCHEMBL695965 | 0.70 | LMNA (0.47) | L3MBTL1LMNAMAPK1HTTNPC1 | |
| SCHEMBL695964 | 0.70 | LMNA (0.47) | L3MBTL1LMNAMAPK1HTTNPC1 | |
| SCHEMBL6345600 | 0.70 | LMNA (0.47) | L3MBTL1LMNAMAPK1HTTNPC1 | |
| SCHEMBL697998 | 0.68 | GFER (0.38) | L3MBTL1LMNAMAPK1HTTNPC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1407667-B1 | HERBICIDE CONTAINING SUBSTITUTED PYRAZOLE DERIVATIVE AS ACTIVE INGREDIENT | SDS BIOTECH CORP (JP) | 2007-09-26 | — | — | EP | disclosed |
| EP-1464642-B1 | NOVEL SUBSTITUTED PYRAZOLE DERIVATIVE, PROCESS FOR PRODUCING THE SAME, AND HERBICIDAL COMPOSITION CONTAINING THE SAME | SDS BIOTECH CORP (JP) | 2007-08-29 | — | — | EP | disclosed |
| US-7192906-B2 | Substituted pyrazole derivatives, production process thereof, and herbicide compositions containing the derivatives | SDS BIOTECH K.K. (JP) | 2007-03-20 | — | — | US | disclosed |
| EP-0945437-B1 | Pyrazolyl acrylic acid- and pyrazolyl oximino-acetic acid derivatives, their preparation and their use as fungicides | SDS BIOTECH CORP (JP) | 2006-11-02 | — | — | EP | disclosed |
| US-20050014649-A1 | Novel substituted pyrazole derivative, process for producing the same, and herbicidal composition containing the same | SDS BIOTECH K.K. (JP) | 2005-01-20 | — | — | US | disclosed |
| US-6809065-B2 | ON ALGAE OR WEEDS; CROP SELECTIVITY | SDS BIOTECH K.K. (JP) | 2004-10-26 | — | — | US | disclosed |
| EP-1464642-A1 | NOVEL SUBSTITUTED PYRAZOLE DERIVATIVE, PROCESS FOR PRODUCING THE SAME, AND HERBICIDAL COMPOSITION CONTAINING THE SAME | SDS Biotech K.K. (JP) | 2004-10-06 | — | — | EP | disclosed |
| EP-1407667-A1 | HERBICIDE CONTAINING SUBSTITUTED PYRAZOLE DERIVATIVE AS ACTIVE INGREDIENT | SDS Biotech K.K. (JP) | 2004-04-14 | — | — | EP | disclosed |
| US-20040033898-A1 | Herbicide containing substituted pyrazole derivative as active ingredient | SDS BIOTECH K.K. (JP) | 2004-02-19 | — | — | US | disclosed |
| EP-0945437-A1 | Pyrazolyl acrylic acid- and pyrazolyl oximino-acetic acid derivatives, their preparation and their use as fungicides | SDS Biotech K.K. (JP) | 1999-09-29 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050014649-A1 | Novel substituted pyrazole derivative, process for producing the same, and herbicidal composition containing the same | HPD, HDHD5, CYP2E1 | L3MBTL1 3933/4885LMNA 4682/4885MAPK1 2008/4885 |
| US-20040033898-A1 | Herbicide containing substituted pyrazole derivative as active ingredient | DDT, SULT2A1, CYP2E1 | L3MBTL1 4275/4885LMNA 4726/4885MAPK1 1167/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.